SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Novo begins study to find lowest effective dose for Wegovy pill

Novo Nordisk (NVO) begins a study to identify the lowest effective dose for a Wegovy pill formulation,

LLYNVO

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.